| Course | NRS 460 Complex Disease Management |
|---|---|
| Topic | Topic 3 |
| Paper type | Comorbidity case study |
| Length | About 1,000 words, 4 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | RN to BSN |
| Updated | October 2026 |
Free sample paper for NRS 460 Topic 3
Wet Lungs or Tight Airways: A Comorbidity Case Study of a 66-Year-Old Woman With Heart Failure and COPD Who Cannot Catch Her Breath
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
NRS-460: Complex Disease Management
Topic 3 Assignment
[Instructor Name]
January 25, 2027
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
Wet Lungs or Tight Airways: A Comorbidity Case Study of a 66-Year-Old Woman With Heart Failure and COPD Who Cannot Catch Her Breath
The Presentation
Mrs. N. G., 66, arrives at the emergency department at 0600 with three days of worsening shortness of breath. She has chronic obstructive pulmonary disease from 40 years of smoking, quit five years ago, and heart failure with reduced ejection fraction, last measured at 30 percent. At home she uses a long-acting bronchodilator inhaler and takes carvedilol, lisinopril and furosemide 40 milligrams daily. She reports that she has been waking at night unable to breathe and sleeping in a recliner, that her cough has increased, and that her sputum is "a little thicker, still white." She ran out of furosemide five days ago and did not refill it until yesterday. On arrival: respiratory rate 28, heart rate 112 and irregular, blood pressure 148/88, temperature 98.6 F, oxygen saturation 86 percent on room air. She speaks in short phrases. The problem is that her breathlessness could come from fluid in the lungs from failing heart function, from air that cannot leave narrowed airways, or from both.
Weighing the Distinguishing Evidence
The history points first toward heart failure: she stopped her diuretic, she wakes at night breathless and sleeps upright, and her sputum has not changed color, which argues against a bacterial exacerbation of chronic obstructive pulmonary disease. Examination supports it: jugular venous pressure is elevated at 8 centimeters above the sternal angle, both ankles show 2+ pitting edema, her weight is 7 pounds above her dry weight recorded at her last clinic visit, and fine crackles are heard at both lung bases. There is also some wheeze throughout both lung fields, which can occur in chronic obstructive pulmonary disease or from fluid in the airway walls in heart failure.
Laboratory results and imaging settle the balance. Her B-type natriuretic peptide is 1,240 pg/mL. In a large emergency department study of patients with acute shortness of breath, a level of 100 pg/mL or more was accurate in distinguishing heart failure from other causes (Maisel et al., 2002), and her level is far above that. The chest radiograph shows an enlarged heart, vascular congestion and small bilateral pleural effusions, without hyperinflation beyond her baseline or a new infiltrate. An arterial blood gas shows pH 7.36, PaCO2 47 mm Hg and PaO2 54 mm Hg on room air, a mild chronic carbon dioxide retention consistent with her lung disease, not an acute respiratory acidosis. The judgment is that decompensated heart failure is the main driver of this episode, with her chronic lung disease narrowing her margin rather than causing the crisis. That judgment shapes every decision that follows.
Every Decision Stated Twice
Diuresis. For heart failure, intravenous furosemide is the central treatment, removing the excess fluid that is flooding her lungs. For chronic obstructive pulmonary disease, aggressive diuresis carries a specific risk: loss of chloride with the urine can produce a metabolic alkalosis, and the body compensates by breathing less, which can raise carbon dioxide in a patient who already retains it. Resolution: give intravenous furosemide, monitor urine output and weight, and check electrolytes and a repeat blood gas the next morning.
Oxygen. For heart failure, oxygen corrects hypoxemia caused by fluid in the alveoli. For her lung disease, high-flow oxygen can worsen carbon dioxide retention in patients prone to hypercapnia. Resolution: titrate oxygen to a saturation of 88 to 92 percent, the range recommended for patients at risk of hypercapnic respiratory failure (O'Driscoll et al., 2017), which is adequate for her heart.
Bronchodilators. For her lung disease, a nebulized short-acting beta-agonist eases airway narrowing. For her heart, beta-agonists raise heart rate and can provoke arrhythmias, and her rhythm is already irregular and fast. Resolution: give bronchodilators as needed for wheeze rather than on a fixed frequent schedule, with continuous cardiac monitoring, and consider an anticholinergic bronchodilator, which has less effect on heart rate.
Beta-blocker. For heart failure, carvedilol is part of long-term therapy that improves survival; for her lungs, beta-blockade has been feared for causing bronchospasm. Evidence suggests cardioselective beta-blockers do not produce significant adverse respiratory effects in chronic obstructive pulmonary disease (Salpeter et al., 2005). Resolution: continue her beta-blocker at the current dose if blood pressure allows, and at discharge ask whether switching to a more cardioselective agent such as bisoprolol would suit her lungs better, since carvedilol is nonselective.
Corticosteroids. For an exacerbation of lung disease, a short course of systemic steroids is often given. For her heart, steroids cause sodium and fluid retention. Resolution: because the evidence points to heart failure rather than a lung exacerbation, withhold systemic steroids unless wheeze persists after diuresis.
Targets That Respect Both Conditions
Targets are set where they serve one condition without pushing the other into trouble: oxygen saturation 88 to 92 percent; net fluid balance of 1 to 1.5 liters negative a day until she reaches her dry weight; heart rate below 100 at rest; potassium kept at or above 4.0, since both diuretics and beta-agonists lower potassium and her rhythm is irregular; and no sodium restriction stricter than about 2 grams a day, as severe restriction can reduce appetite in patients whose lung disease already makes eating tiring.
Two Time Horizons
In the next hours, the order is: position her upright, titrate oxygen to 88 to 92 percent, place her on a cardiac monitor, give intravenous furosemide, and reassess breathing, saturation, urine output and mental status every hour, watching for drowsiness that could signal rising carbon dioxide. Over the coming months, the order is different: prevent the next admission by making sure she never runs out of her diuretic, using a mail-order pharmacy and a pill organizer; teach daily weights with a clear action at a 3-pound gain; confirm her inhaler technique; refer her to pulmonary rehabilitation, which helps exercise tolerance in lung disease and can be adapted for heart failure; and schedule follow-up with both her cardiologist and her primary provider within a week of discharge (Rogers, 2023).
References
Maisel, A. S., Krishnaswamy, P., Nowak, R. M., McCord, J., Hollander, J. E., Duc, P., Omland, T., Storrow, A. B., Abraham, W. T., Wu, A. H. B., Clopton, P., Steg, P. G., Westheim, A., Knudsen, C. W., Perez, A., Kazanegra, R., Herrmann, H. C., & McCullough, P. A. (2002). Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New England Journal of Medicine, 347(3), 161-167. https://doi.org/10.1056/NEJMoa020233
O'Driscoll, B. R., Howard, L. S., Earis, J., & Mak, V. (2017). BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax, 72(Suppl. 1), ii1-ii90. https://doi.org/10.1136/thoraxjnl-2016-209729
Rogers, J. L. (Ed.). (2023). McCance & Huether's pathophysiology: The biologic basis for disease in adults and children (9th ed.). Elsevier.
Salpeter, S. R., Ormiston, T. M., & Salpeter, E. E. (2005). Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, (4), Article CD003566. https://doi.org/10.1002/14651858.CD003566.pub2
NRS 460 Topic 3 instructions, in plain terms
Topic 3 in NRS-460 asks students to analyze a patient with two interacting conditions. Strong case studies weigh the evidence that distinguishes which condition is producing the current crisis, then state every treatment decision twice, considering its effect on each condition. Students should set targets that serve one condition without harming the other, such as oxygen saturation ranges that suit COPD, and plan across time horizons, from the next hours to discharge. The analysis may name a drug that guidelines discourage for one condition if the evidence supports it, and background should include only what the decisions need. A short table of decisions with their effect on each condition helps faculty follow the reasoning.
How this NRS 460 Topic 3 example is built
The finished case study never separates the two conditions into their own halves. The presentation comes first and it is deliberately ambiguous, since the same shortness of breath can come from fluid in the lungs or from air that cannot leave them. The example then works the distinguishing evidence: the history of the change, the swelling, the sputum, the response to sitting up, the natriuretic peptide, the imaging. From there every decision is stated twice, once for each condition, and then resolved. Diuresis is set against dehydration and thickened secretions, oxygen carries a target that respects carbon dioxide retention, and a beta blocker is chosen for selectivity rather than avoided outright. Monitoring is written for the interference rather than for either disease alone.
Where the marks sit in the NRS 460 Topic 3 rubric
Faculty reward each decision weighed for both conditions. An Excellent case study weighs the stopped diuretic, orthopnea and unchanged sputum, using Maisel and colleagues on BNP to favor heart failure. Credit goes to stating diuresis, bronchodilators and beta blockers twice, citing Salpeter and colleagues on cardioselective beta blockers in COPD. The rubric values a saturation target of 88 to 92 percent from O'Driscoll and colleagues and a stated fluid goal. Strong papers use Rogers for mechanism. Top marks go to an hours plan and a discharge plan.
NRS 460 Topic 3 help before you submit
The failure this topic is built to expose is two plans in one paper. A section on heart failure followed by a section on chronic lung disease, each competent, earns far less than the rubric offers, because nothing in it addresses the patient who has both. Attributing the breathlessness to one condition without weighing the other is the second loss, and it makes every decision downstream unsafe reasoning. Avoiding a whole drug class out of habit is a third, since blanket avoidance is not the same as a considered choice with a reason and a monitoring plan. Oxygen written without a target range misses the interference entirely. Strong versions commit to which condition is driving today and say what evidence would change that judgment.
Get an NRS-460 Topic 3 example written to your instructions
Send the case, the assignment instructions and the rubric from your NRS 460 classroom. We write a custom example to those criteria, with the interference between the two conditions named and resolved rather than avoided, and return it in 24 to 48 hours. The first custom sample is free.
More NRS 460 papers and RN to BSN samples
- NRS 460 Topic 1: Illness Trajectory Paper
- NRS 460 Topic 2: Polypharmacy Review
- NRS 460 Topic 4: Care Plan
- NRS 460 Topic 5: Care Transition Plan
- NRS 460 Topic 6: Functional Status Write-up
- NRS 460 Topic 7: Goals of Care Write-up
- NRS 460 Topic 8: Comprehensive Management Plan
- NRS 465 Topic 3: Literature Synthesis
- NRS 455 Topic 3: Lab Value Interpretation
- PHI 413V Topic 3: ICD Deactivation Ethical Analysis
- NRS 450 Topic 3: Interoperability Analysis
NRS 460 Topic 3 questions, answered
Which condition should the plan prioritize?
Whichever is producing the immediate threat, judged from the evidence in your case rather than from a general rule. The example commits to an answer and says what would change it, because a paper treating both as equally urgent has avoided the reasoning this topic asks for. Long term priority often lands elsewhere, and the plan can say so.
Is it acceptable to name a drug the guidelines discourage?
Yes, when the reasoning is shown. Complex patients regularly need a choice that a single condition guideline would not make, and the credit sits in weighing benefit against interference, naming the safeguard and defining what would be monitored. What loses marks is either following one guideline blindly or departing from it without saying why. Never write it as advice.
How much detail belongs in the case background?
Enough to make the conflict real and no more. Age, the age of each diagnosis, kidney function, current medications, recent hospital contacts and living situation usually carry it. Extended social history that never affects a decision reads as padding. Anything you include should be used somewhere in the plan, and anything you never use can come out.
Where can I find a free NRS 460 Topic 3 sample paper?
The comorbidity case for NRS 460 Topic 3 for NRS 460 Topic 3 covers the presentation, weighing the distinguishing evidence, every decision stated twice, targets that respect both conditions and two time horizons. Post your NRS 460 Topic 3 prompt and get a free paper.
Can a beta blocker be used with COPD in NRS 460 Topic 3?
Cardioselective beta blockers are generally tolerated and help heart failure, as a meta-analysis by Salpeter and colleagues found, so the paper keeps one while watching for bronchospasm.